|
1
|
Van Meir EG, Hadjipanayis CG, Norden AD,
Shu H-K, Wen PY and Olson JJ: Exciting new advances in
neuro-oncology: the avenue to a cure for malignant glioma. CA
Cancer J Clin. 60:166–193. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Surawicz TS, McCarthy BJ, Kupelian V,
Jukich PJ, Bruner JM and Davis FG: Descriptive epidemiology of
primary brain and CNS tumors: results from the Central Brain Tumor
Registry of the United States, 1990–1994. Neuro Oncol. 1:14–25.
1999.
|
|
3
|
Stupp R, Mason WP, van den Bent MJ, et al:
Radiotherapy plus concomitant and adjuvant temozolomide for
glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang X: The expanding role of mitochondria
in apoptosis. Genes Dev. 15:2922–2933. 2001.PubMed/NCBI
|
|
5
|
Ghobrial IM, Witzig TE and Adjei AA:
Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin.
55:178–194. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Youle RJ and Strasser A: The BCL-2 protein
family: opposing activities that mediate cell death. Nat Rev Mol
Cell Biol. 9:47–59. 2008. View
Article : Google Scholar
|
|
7
|
Yip KW and Reed JC: Bcl-2 family proteins
and cancer. Oncogene. 27:6398–6406. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Green DR and Chipuk JE: Apoptosis: stabbed
in the BAX. Nature. 455:1047–1049. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cheng EH, Wei MC, Weiler S, et al: BCL-2,
BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and
BAK-mediated mitochondrial apoptosis. Mol Cell. 8:705–711. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gross A, McDonnell JM and Korsmeyer SJ:
BCL-2 family members and the mitochondria in apoptosis. Genes Dev.
13:1899–1911. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim H, Rafiuddin-Shah M, Tu H-C, et al:
Hierarchical regulation of mitochondrion-dependent apoptosis by
BCL-2 subfamilies. Nat Cell Biol. 8:1348–1358. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wei MC, Lindsten T, Mootha VK, et al:
tBID, a membrane-targeted death ligand, oligomerizes BAK to release
cytochrome c. Genes Dev. 14:2060–2071. 2000.PubMed/NCBI
|
|
13
|
Wei MC, Zong WX, Cheng EH, et al:
Proapoptotic BAX and BAK: a requisite gateway to mitochondrial
dysfunction and death. Science. 292:727–730. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Willis SN, Chen L, Dewson G, et al:
Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2,
until displaced by BH3-only proteins. Genes Dev. 19:1294–1305.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Walensky LD: Playing fullBAK. Cell Cycle.
12:1333–1334. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Certo M, Del Gaizo Moore V, Nishino M, et
al: Mitochondria primed by death signals determine cellular
addiction to anti-apoptotic BCL-2 family members. Cancer Cell.
9:351–365. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kuwana T, Bouchier-Hayes L, Chipuk JE, et
al: BH3 domains of BH3-only proteins differentially regulate
Bax-mediated mitochondrial membrane permeabilization both directly
and indirectly. Mol Cell. 17:525–535. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Letai A, Bassik MC, Walensky LD,
Sorcinelli MD, Weiler S and Korsmeyer SJ: Distinct BH3 domains
either sensitize or activate mitochondrial apoptosis, serving as
prototype cancer therapeutics. Cancer Cell. 2:183–192. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim H, Tu H-C, Ren D, et al: Stepwise
activation of BAX and BAK by tBID, BIM, and PUMA initiates
mitochondrial apoptosis. Mol Cell. 36:487–499. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sattler M, Liang H, Nettesheim D, et al:
Structure of Bcl-xL-Bak peptide complex: recognition between
regulators of apoptosis. Science. 275:983–986. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Walensky LD: BCL-2 in the crosshairs:
tipping the balance of life and death. Cell Death Differ.
13:1339–1350. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Scorilas A, Kyriakopoulou L, Yousef GM,
Ashworth LK, Kwamie A and Diamandis EP: Molecular cloning, physical
mapping, and expression analysis of a novel gene, BCL2L12, encoding
a proline-rich protein with a highly conserved BH2 domain of the
Bcl-2 family. Genomics. 72:217–221. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chou C-H, Chou A-K, Lin C-C, et al: GSK3β
regulates Bcl2L12 and Bcl2L12A anti-apoptosis signaling in
glioblastoma and is inhibited by LiCl. Cell Cycle. 11:532–542.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Stegh AH, Brennan C, Mahoney JA, et al:
Glioma oncoprotein Bcl2L12 inhibits the p53 tumor suppressor. Genes
Dev. 24:2194–2204. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hong Y, Yang J, Wu W, et al: Knockdown of
BCL2L12 leads to cisplatin resistance in MDA-MB-231 breast cancer
cells. Biochim Biophys Acta. 1782:649–657. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Thomadaki H, Talieri M and Scorilas A:
Prognostic value of the apoptosis related genes BCL2 and BCL2L12 in
breast cancer. Cancer Lett. 247:48–55. 2007. View Article : Google Scholar
|
|
27
|
Florou D, Papadopoulos IN and Scorilas A:
Molecular analysis and prognostic impact of the novel apoptotic
gene BCL2L12 in gastric cancer. Biochem Biophys Res Commun.
391:214–218. 2010. View Article : Google Scholar
|
|
28
|
Furnari FB, Fenton T, Bachoo RM, et al:
Malignant astrocytic glioma: genetics, biology, and paths to
treatment. Genes Dev. 21:2683–2710. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lin CJ, Lee CC, Shih YL, et al:
Resveratrol enhances the therapeutic effect of temozolomide against
malignant glioma in vitro and in vivo by inhibiting autophagy. Free
Radic Biol Med. 52:377–391. 2012. View Article : Google Scholar
|
|
30
|
Czabotar PE, Lee EF, Thompson GV, Wardak
AZ, Fairlie WD and Colman PM: Mutation to Bax beyond the BH3 domain
disrupts interactions with pro-survival proteins and promotes
apoptosis. J Biol Chem. 286:7123–7131. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Roy A, Xu D, Poisson J and Zhang Y: A
protocol for computer-based protein structure and function
prediction. JoVE. e32592011.PubMed/NCBI
|
|
32
|
Yachdav G, Kloppmann E, Kajan L, et al:
PredictProtein - an open resource for online prediction of protein
structural and functional features. Nucleic Acids Res.
42:W337–W343. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bhat V, Olenick MB, Schuchardt BJ, Mikles
DC, McDonald CB and Farooq A: Molecular determinants of the binding
specificity of BH3 ligands to BclXL apoptotic repressor.
Biopolymers. 101:573–582. 2014. View Article : Google Scholar
|
|
34
|
Czabotar PE, Westphal D, Dewson G, et al:
Bax crystal structures reveal how BH3 domains activate Bax and
nucleate its oligomerization to induce apoptosis. Cell.
152:519–531. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wysoczanski P, Mart RJ, Loveridge EJ, et
al: NMR solution structure of a photo-switchable apoptosis
activating Bak peptide bound to Bcl-xL. J Am Chem Soc.
134:7644–7647. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Petros AM, Medek A, Nettesheim DG, et al:
Solution structure of the antiapoptotic protein bcl-2. Proc Natl
Acad Sci USA. 98:3012–3017. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Suzuki M, Youle RJ and Tjandra N:
Structure of Bax: coregulation of dimer formation and intracellular
localization. Cell. 103:645–654. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Stegh AH, Kim H, Bachoo RM, et al: Bcl2L12
inhibits post-mitochondrial apoptosis signaling in glioblastoma.
Genes Dev. 21:98–111. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Stegh AH, Kesari S, Mahoney JE, et al:
Bcl2L12-mediated inhibition of effector caspase-3 and caspase-7 via
distinct mechanisms in glioblastoma. Proc Natl Acad Sci USA.
105:10703–10708. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Stegh AH and DePinho RA: Beyond effector
caspase inhibition: Bcl2L12 neutralizes p53 signaling in
glioblastoma. Cell Cycle. 10:33–38. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hong YR: False positive: detection and
elimination. Yeast Hybrid Methods. Zhu L and Hannon G: Eaton
publishing; Natick, MA: pp. 101–113. 2000
|
|
42
|
Higgins GC, Devenish RJ, Beart PM and
Nagley P: Autophagic activity in cortical neurons under acute
oxidative stress directly contributes to cell death. Cell Mol Life
Sci. 68:3725–3740. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Simonin K, N’Diaye M, Lheureux S, et al:
Platinum compounds sensitize ovarian carcinoma cells to ABT-737 by
modulation of the Mcl-1/Noxa axis. Apoptosis. 18:492–508. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Oltersdorf T, Elmore SW, Shoemaker AR, et
al: An inhibitor of Bcl-2 family proteins induces regression of
solid tumours. Nature. 435:677–681. 2005. View Article : Google Scholar : PubMed/NCBI
|
